Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sinovac Rabies Vaccine (Serum-free Vero Cell) PrEP Phase 3
NCT07055295Phase 3Not yet recruiting
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Mar 2026
- Primary completion
- Dec 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Rabies Vaccine (Serum-free Vero Cell) in rabies, sponsored by Sinovac Biotech Ltd.. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
Rabies Vaccine (Serum-free Vero Cell)
03
Conditions
rabies
Beyond the preview
Go deeper on NCT07055295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07055295.